Trial Condition(s):

Postmenopause

Efficacy and Tolerability of Angeliq in Thai women

Bayer Identifier:

91436

ClinicalTrials.gov Identifier:

NCT00185328

EudraCT Number:

Not Available

Study Completed

Trial Purpose

To evaluate the safety, tolerability, and efficacy of Angeliq in Thai post menopausal women with hot flushes and other climacteric symptoms.

Inclusion Criteria
- Postmenopausal women with hot flushes
Exclusion Criteria
- Women with a contraindication for Hormone Replacement Therapy (HRT)

Trial Summary

Enrollment Goal
55
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Angeliq (E2/DRSP, BAY86-4891)
Accepts Healthy Volunteers
No

Where to Participate

Locations
Status
LocationsStatus

Trial Design